留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

北京市超重肥胖儿童内脏脂肪指数与非酒精性脂肪肝的关系

李印东 李梦龙 段军伟 书文 李子昂 甄国新 赵瑞兰 胡翼飞

李印东, 李梦龙, 段军伟, 书文, 李子昂, 甄国新, 赵瑞兰, 胡翼飞. 北京市超重肥胖儿童内脏脂肪指数与非酒精性脂肪肝的关系[J]. 中国学校卫生, 2021, 42(5): 659-662. doi: 10.16835/j.cnki.1000-9817.2021.05.005
引用本文: 李印东, 李梦龙, 段军伟, 书文, 李子昂, 甄国新, 赵瑞兰, 胡翼飞. 北京市超重肥胖儿童内脏脂肪指数与非酒精性脂肪肝的关系[J]. 中国学校卫生, 2021, 42(5): 659-662. doi: 10.16835/j.cnki.1000-9817.2021.05.005
LI Yindong, LI Menglong, DUAN Junwei, SHU Wen, LI Ziang, ZHEN Guoxin, ZHAO Ruilan, HU Yifei. Association between visceral adiposity index and non-alcoholic fatty liver among overweight and obese children in Beijing[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2021, 42(5): 659-662. doi: 10.16835/j.cnki.1000-9817.2021.05.005
Citation: LI Yindong, LI Menglong, DUAN Junwei, SHU Wen, LI Ziang, ZHEN Guoxin, ZHAO Ruilan, HU Yifei. Association between visceral adiposity index and non-alcoholic fatty liver among overweight and obese children in Beijing[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2021, 42(5): 659-662. doi: 10.16835/j.cnki.1000-9817.2021.05.005

北京市超重肥胖儿童内脏脂肪指数与非酒精性脂肪肝的关系

doi: 10.16835/j.cnki.1000-9817.2021.05.005
基金项目: 

国家自然科学基金资助项目 82073574

北京市自然科学基金资助项目 7202009

北京市教委科技计划一般项目 KM201810025009

详细信息
    作者简介:

    李印东(1964-),男,北京市人,大学本科,主任医师,主要从事疾病预防控制工作

    李梦龙(1995-),男,安徽省人,在读硕士,主要研究方向为儿童青少年期慢性病预防

    通讯作者:

    胡翼飞,E-mail:huyifei@yahoo.com

  • 李印东与李梦龙为共同第一作者。
  • 中图分类号: R 723.14 R 575.5

Association between visceral adiposity index and non-alcoholic fatty liver among overweight and obese children in Beijing

  • 摘要:   目的  探索超重肥胖儿童内脏脂肪指数(visceral adiposity index, VAI)与非酒精性脂肪肝(non-alcoholic fatty liver disease, NAFLD)的关系,为儿童NAFLD早期预防和分层干预提供参考依据。  方法  研究对象来自北京儿童生长与健康队列(PROC),经数据清理整合后纳入具有完整的肝脏超声和VAI数据的6~8岁超重肥胖儿童510名。采用Spearman秩相关分析探索VAI与NAFLD的相关系数,采用趋势χ2检验和Logistic回归分析确定VAI分组与NAFLD的关系。  结果  男、女童NAFLD检出率分别为25.9%(69名)和11.1%(27名)。正常组和NAFLD组男童VAI为0.43(0.31,0.61)和0.61(0.44,0.87);女童为0.74(0.56,1.07)和1.08(0.67,1.51)。男童和女童中三酰甘油(TG)、VAI和VAI三分位分组与NAFLD呈正相关(r值分别为0.19,0.26,0.29;0.16,0.16,0.18,P值均 < 0.05),男童高密度脂蛋白胆固醇(HDL-C)与NAFLD呈负相关(r=-0.21,P < 0.05)。随着VAI分位数的增加,男女童NAFLD检出率有增加的趋势(χ趋势2值分别为21.77,7.66,P值均 < 0.01)。单因素和多因素Logistic回归结果显示,以VAI第1三分位数为参照,男童第2三分位数(cOR=2.59,95%CI=1.15~5.86;aOR=2.33,95%CI=1.01~5.36)和第3三分位数(cOR=5.73,95%CI=2.62~12.53;aOR=4.87,95%CI=2.15~11.03)患NAFLD的风险增加; 女童第3三分位数(cOR=4.43,95%CI=1.40~14.00)患NAFLD的风险增加。  结论  VAI与NAFLD呈正相关,超重肥胖儿童患NAFLD风险随VAI分位数增加而增加,可应用VAI进行NAFLD分层管理。
    1)  李印东与李梦龙为共同第一作者。
  • 表  1  不同性别是否NAFLD超重肥胖儿童基本指标比较(x±s)

    Table  1.   Comparison of influencing factors between normal and NAFLD group by sex among children with overweight and obesity(x±s)

    性别 组别 人数 统计值 年龄/岁 身高/cm 腰围/cm BMI/(kg·m-2) SBP/mm Hg DBP/mm Hg 空腹血糖/(mmol·L-1)
    正常 197 6.7±0.3 125.3±5.1 63.6±7.0 19.0±2.3 99.8±9.2 54.0±6.9 5.2±0.5
    NAFLD 69 6.7±0.3 128.0±4.2 72.2±7.7 22.3±2.9 103.6±9.7 55.8±6.7 5.2±0.3
    t -0.85 -4.03 -8.64 -9.38 -2.86 -1.87 0.22
    P 0.40 < 0.01 < 0.01 < 0.01 < 0.01 0.06 0.82
    正常 217 6.7±0.3 123.7±5.0 61.5±6.3 18.5±2.1 98.9±9.2 53.8±6.5 5.1±0.4
    NAFLD 27 6.6±0.3 127.5±5.2 69.4±7.0 21.4±2.7 99.5±9.3 53.8±4.5 5.0±0.3
    t 0.45 -6.08 -6.08 -5.45 -0.31 0.05 0.99
    P 0.65 < 0.01 < 0.01 < 0.01 0.76 0.96 0.33
    注: 1 mm Hg=0.133 kPa。
    下载: 导出CSV

    表  2  不同性别是否NAFLD超重肥胖儿童脂类指标比较[M(P25P75)]

    Table  2.   Comparison of lipid indexes between normal and NAFLD group by sex among children with overweight and obesity [M(P25, P75)]

    性别 组别 人数 统计值 TC/(mmol·L-1) LDL-C/(mmol·L-1) HDL-C/(mmol·L-1) TG/(mmol·L-1) VAI
    正常 197 4.52(4.05, 4.96) 2.49(2.12, 2.85) 1.54(1.36, 1.75) 0.61(0.49, 0.82) 0.43(0.31, 0.61)
    NAFLD 69 4.37(3.91, 4.99) 2.42(1.88, 3.03) 1.41(1.26, 1.55) 0.80(0.56, 1.00) 0.61(0.44, 0.87)
    Z 0.69 0.13 3.35 -3.13 -4.24
    P 0.49 0.90 < 0.01 < 0.01 < 0.01
    正常 217 4.45(4.02, 4.91) 2.43(2.13, 2.86) 1.47(1.29, 1.70) 0.71(0.54, 0.90) 0.74(0.56, 1.07)
    NAFLD 27 4.76(3.86, 5.35) 2.73(2.19, 3.11) 1.37(1.23, 1.59) 0.94(0.63, 1.09) 1.08(0.67, 1.51)
    Z -0.96 -1.85 1.38 -2.43 -2.56
    P 0.34 0.06 0.17 0.02 0.01
    下载: 导出CSV

    表  3  不同性别超重肥胖儿童多种代谢指标与NAFLD的相关性

    Table  3.   Correlation between metabolic indexes and NAFLD by sex among children with overweight and obesity

    变量 男童(n=266) 女童(n=244)
    r P r P
    空腹血糖/(mmol·L-1) -0.03 0.65 -0.10 0.11
    TC/(mmol·L-1) -0.04 0.49 0.06 0.34
    LDL-C/(mmol·L-1) -0.01 0.90 0.12 0.06
    HDL-C/(mmol·L-1) -0.21 < 0.01 -0.09 0.17
    TG/(mmol·L-1) 0.19 < 0.01 0.16 0.02
    VAI 0.26 < 0.01 0.16 0.01
    VAI三分位分组 0.29 < 0.01 0.18 < 0.01
    下载: 导出CSV
  • [1] FITZPATRICK E. Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum[J]. Proc Nutr Soc, 2019, 78(3): 362-371. doi: 10.1017/S0029665118002914
    [2] YOUNOSSI Z, TACKE F, ARRESE M, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Hepatology, 2019, 69(6): 2672-2682. doi: 10.1002/hep.30251
    [3] CIMINI F A, BARCHETTA I, CICCARELLI G, et al. Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease[J]. Diabet Metab Res Rev, 2021, 37(1): e3358. http://www.researchgate.net/publication/341743045_Adipose_tissue_remodelling_in_obese_subjects_is_a_determinant_of_presence_and_severity_of_fatty_liver_disease
    [4] CALCATERRA V, REGALBUTO C, PORRI D, et al. Inflammation in obesity-related complications in children: the protective effect of diet and its potential role as a therapeutic agent[J]. Biomolecules, 2020, 10(9): 1324. doi: 10.3390/biom10091324
    [5] 杨琴, 曾祥士, 代东伶. 儿童非酒精性脂肪性肝病相关的脂质代谢基因变异及生物学信息分析[J]. 中华实用儿科临床杂志, 2019, 34(19): 1458-1461.

    YANG Q, ZENG X S, DAI D L. Genetic variation and biological information analysis of lipid metabolism associated with non-alcoholic fatty liver disease in children[J]. Chin J Appl Clin Pediatr, 2019, 34(19): 1458-1461.
    [6] SCHETZ M, DE JONG A, DEANE A M, et al. Obesity in the critically ill: a narrative review[J]. Inten Care Med, 2019, 45(6): 757-769. doi: 10.1007/s00134-019-05594-1
    [7] KWAK J H, JUN D W, LEE S M, et al. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: a cross-sectional study[J]. Clin Nutr, 2018, 37(5): 1550-1557. doi: 10.1016/j.clnu.2017.08.018
    [8] OOI G J, BURTON P R, BAYLISS J, et al. Effect of body mass index, metabolic health and adipose tissue inflammation on the severity of non-alcoholic fatty liver disease in bariatric surgical patients: a prospective study[J]. Obes Surg, 2019, 29(1): 99-108. doi: 10.1007/s11695-018-3479-2
    [9] AMATO M C, GIORDANO C, GALIA M, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk[J]. Diabetes Care, 2010, 33(4): 920-922. doi: 10.2337/dc09-1825
    [10] XU C, MA Z, WANG Y, et al. Visceral adiposity index as a predictor of NAFLD: a prospective study with 4-year follow-up[J]. Liver Int, 2018, 38(12): 2294-2300. doi: 10.1111/liv.13941
    [11] OKAMURA T, HASHIMOTO Y, HAMAGUCHI M, et al. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: a population-based longitudinal study[J]. Clin Res Hepatol Gastroenterol, 2020, 44(3): 375-383. doi: 10.1016/j.clinre.2019.04.002
    [12] 国家卫生和计划生育委员会. 学龄儿童青少年超重与肥胖筛查WS/T 586—2018[S]. 北京: 中国标准出版社, 2018.

    National Health Commission of the People's Republic of China. Screening for overweight and obesity among school-age children and adolescents WS/T 586-2018[S]. Beijing: China Standards Press, 2018.
    [13] 周雪莲, 傅君芬. 儿童非酒精性脂肪肝病诊断与治疗专家共识[J]. 中国实用儿科杂志, 2018, 33(7): 12-17. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201807002.htm

    ZHOU X L, FU J F. Expert consensus on the diagnosis and treatment of non-alcoholic fatty liver disease in children[J]. Chin J Pract Pediatr, 2018, 33(7): 12-17. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201807002.htm
    [14] 范歆, 陈少科, 唐晴, 等. 南宁市超重、肥胖儿童非酒精性脂肪肝患病情况分析[J]. 中国儿童保健杂志, 2012, 20(2): 124-126. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO201202010.htm

    FAN X, CHEN S K, TANG Q, et al. Analysis of incidence of non-alcoholic fatty liver disease in overweight and obesity children in Nanning[J]. Chin J Child Health Care, 2012, 20(2): 124-126. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO201202010.htm
    [15] LONARDO A, NASCIMBENI F, BALLESTRI S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps[J]. Hepatology, 2019, 70(4): 1457-1469. doi: 10.1002/hep.30626
    [16] DRAIJER L G, FROON-TORENSTRA D, VAN WEEGHEL M, et al. Lipidomics in nonalcoholic fatty liver disease: exploring serum lipids as biomarkers for pediatric nonalcoholic fatty liver disease[J]. J Pediatr Gastroenterol Nutr, 2020, 71(4): 433-439. doi: 10.1097/MPG.0000000000002875
    [17] OZSU E, YAZICIOGLU B. Obese boys with low concentrations of high-density lipoprotein cholesterol are at greater risk of hepatosteatosis[J]. Hormones(Athens), 2019, 18(4): 477-484. doi: 10.1007/s42000-019-00152-2
    [18] 张云飞, 杨丽丽, 席波, 等. 代谢异常指标聚集性与高血压儿童青少年非酒精性脂肪肝的关系[J]. 中国学校卫生, 2019, 40(6): 809-811. https://www.cnki.com.cn/Article/CJFDTOTAL-XIWS201906007.htm

    ZHANG Y F, YANG L L, XI B, et al. Association of clustering of metabolic abnormalities with non-alcoholic fatty liver disease in hypertensive children and adolescents[J]. Chin J Sch Health, 2019, 40(6): 809-811. https://www.cnki.com.cn/Article/CJFDTOTAL-XIWS201906007.htm
  • 加载中
表(3)
计量
  • 文章访问数:  574
  • HTML全文浏览量:  319
  • PDF下载量:  54
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-01-17
  • 修回日期:  2021-04-09
  • 网络出版日期:  2021-05-20
  • 刊出日期:  2021-05-25

目录

    /

    返回文章
    返回